Amid shifting global dynamics, the question remains: what's next? In answering this question, it's important to explore past and present VC trends in both countries while looking to emerging trends for a glimpse of what's to come.
Chinese utonomous driving solution provider Uisee announced that it has obtained Bosch's strategic investment in a series B financing. Other investors include Shenzhen Venture Capital, CICC Capital, and other Chinese venture, private equity and local strategic emerging industry funds. The amount of financing for this round was not disclosed. Uisee was founded in 2016. Based [...] Chinese Self-Driving Firm Uisee Secures Funding From Bosch comes from China Money Network: Primary Data for China's Primary Markets! All Rights Reserved.
Veev Secures $97M To Advance Panelized Building System Series B Co-led By Zeev Ventures And Lennar Ventures
Veev Secures $97 Million to Advance Panelized Building System Series B Co-Led by Zeev Ventures and Lennar Ventures SAN MATEO, Calif., February 27, 2020-- Veev Group Inc., an integrated real estate developer, today announced that it has raised $97 million to date and closed its Series B funding round co-led by Zeev Ventures and Lennar Ventures, which drives Lennar Corporation's technology and innovation strategies. The funding includes $85M in equity and $12M in debt and will be used to accelerate the development of the Veev panelized building system, as well as to scale the business.
Axialhealthcare Announces $15M In Series C Funding To Support Expansion Into Substance Use Disorder Treatment And Recovery Sector
axialHealthcare Announces $15 Million in Series C Funding to Support Expansion into Substance Use Disorder Treatment and Recovery Sector NASHVILLE, Tenn., February 27, 2020-- axialHealthcare, a care optimization company navigating substance use issues for patients, providers, and health plans, today announced it has closed $15 million in equity financing to accelerate its expansion into the substance use disorder (SUD) treatment and recovery sector, led by previous institutional investors Oak HC/FT, .406 Ventures, BlueCross BlueShield Venture Partners (BCBSVP), and Sandbox Advantage Fund.
Florian Brand helped start ATAI Life Sciences with one vision in mind: to effectively treat mental-health disorders by turning psychedelics into medicines. The way to do that? By bringing psychedelics through clinical trials and getting approval from regulatory agencies. Prominent backers like Mike Novogratz, Peter Thiel, Thor Bjorgolfsson, and Steve Jurvetson have come on board with this vision, investing over $100 million in ATAI. More recently, traditional biotech and pharmaceutical investors have shown interest as well. ATAI plans to raise a fresh round of funding, Brand said.
SAN FRANCISCO, CA, MycoWorks has raised $17 million in Series A financing led by DCVC Bio.
Tractable Raises $25M In Series C Investment Round, Led By Georgian Partners, To Further Scale Ai For Accident And Disaster Recovery Worldwide
NEW YORK, Feb. 27, 2020 /PRNewswire/ -- Tractable, the technology company developing AI for accident and disaster recovery, today announces a $25m Series C investment, led by Georgian Partners with participation from existing investors, including Insight Partners and Ignition Partners....
Dahmakan, a full-stack food delivery startup based in Malaysia, announced today that it has closed a $18 million Series B. Investors include Rakuten Capital, White Star Capital, JAFCO Asia and GEC-KIP Fund, along with participation from South Korean food delivery app Woowa Brothers, and returning investors Partech Partners and Y Combinator. This brings Dahmakan's total [...]